Identification and quantification of viable Bifidobacterium breve strain Yakult in human faeces by using strain-specific primers and propidium monoazide.
Fujimoto
J
J
Yakult Central Institute for Microbiological Research, Kunitachi, Tokyo, Japan. junji-fujimoto@yakult.co.jp
Tanigawa
K
K
Kudo
Y
Y
Makino
H
H
Watanabe
K
K
D001386:Azides; D001644:Bifidobacterium / Q000235:genetics / Q000302:isolation & purification*; D017931:DNA Primers / Q000737:chemistry; D005243:Feces / Q000382:microbiology*; D006801:Humans; D007364:Intercalating Agents; D050296:Microbial Viability; D016133:Polymerase Chain Reaction / Q000379:methods; D019936:Probiotics; D011419:Propidium / Q000031:analogs & derivatives*; D019105:Random Amplified Polymorphic DNA Technique; D013045:Species Specificity
D001386:Azides; D017931:DNA Primers; D007364:Intercalating Agents; C533957:propidium monoazide; D011419:Propidium